291 related articles for article (PubMed ID: 28218964)
1. Temporal trends in minimally invasive myomectomy before and after the US Food and Drug Administration recommendation against electric morcellation.
Pereira N; Frankel WC; Hutchinson AP; Patel HH; Mostisser C; Elias RT
Int J Gynaecol Obstet; 2017 Jun; 137(3):295-300. PubMed ID: 28218964
[TBL] [Abstract][Full Text] [Related]
2. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy.
Barron KI; Richard T; Robinson PS; Lamvu G
Obstet Gynecol; 2015 Dec; 126(6):1174-1180. PubMed ID: 26595561
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines.
Glaser LM; Friedman J; Tsai S; Chaudhari A; Milad M
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():99-112. PubMed ID: 29078975
[TBL] [Abstract][Full Text] [Related]
4. Minilaparotomy Versus Laparoscopic Myomectomy After Cessation of Power Morcellation: Rate of Wound Complications.
Dubin AK; Wei J; Sullivan S; Udaltsova N; Zaritsky E; Yamamoto MP
J Minim Invasive Gynecol; 2017; 24(6):946-953. PubMed ID: 28552622
[TBL] [Abstract][Full Text] [Related]
5. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.
Matsushita T; Sekizawa A; Jacobs LK
J Minim Invasive Gynecol; 2020 Jan; 27(1):178-185.e1. PubMed ID: 30936031
[TBL] [Abstract][Full Text] [Related]
7. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
9. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
[TBL] [Abstract][Full Text] [Related]
10. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
Clark NM; Schembri M; Jacoby VL
Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal Washings After Power Morcellation in Laparoscopic Myomectomy: A Pilot Study.
Toubia T; Moulder JK; Schiff LD; Clarke-Pearson D; O'Connor SM; Siedhoff MT
J Minim Invasive Gynecol; 2016; 23(4):578-81. PubMed ID: 26867701
[TBL] [Abstract][Full Text] [Related]
12. Perioperative Narcotic Trends in Women Undergoing Minimally Invasive Myomectomy.
Tyan P; Klebanoff JS; Smith S; Amdur R; North A; Maassen MS; Moawad GN
J Minim Invasive Gynecol; 2020; 27(6):1383-1388.e1. PubMed ID: 31600573
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic-Assisted Myomectomy with Bilateral Uterine Artery Occlusion/Ligation.
MacKoul P; Baxi R; Danilyants N; van der Does LQ; Haworth LR; Kazi N
J Minim Invasive Gynecol; 2019; 26(5):856-864. PubMed ID: 30170179
[TBL] [Abstract][Full Text] [Related]
14. Trends in Mode of Hysterectomy After the U.S. Food and Drug Administration Power Morcellation Advisory.
Ottarsdottir H; Cohen SL; Cox M; Vitonis A; Einarsson JI
Obstet Gynecol; 2017 Jun; 129(6):1014-1021. PubMed ID: 28486371
[TBL] [Abstract][Full Text] [Related]
15. Sydney contained in bag morcellation for laparoscopic myomectomy.
Kanade TT; McKenna JB; Choi S; Tsai BP; Rosen DM; Cario GM; Chou D
J Minim Invasive Gynecol; 2014; 21(6):981. PubMed ID: 25048568
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic Features of Uterine Scar after Laparoscopic and Laparoscopy-Assisted Minilaparotomy Myomectomy: A Comparative Study.
Asgari Z; Salehi F; Hoseini R; Abedi M; Montazeri A
J Minim Invasive Gynecol; 2020 Jan; 27(1):148-154. PubMed ID: 31301467
[TBL] [Abstract][Full Text] [Related]
17. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.
Pereira N; Buchanan TR; Wishall KM; Kim SH; Grias I; Richard SD; Della Badia CR
J Minim Invasive Gynecol; 2015 Feb; 22(2):163-76. PubMed ID: 25218993
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Myomectomy: A Single-center Retrospective Review of 514 Patients.
Bean EM; Cutner A; Holland T; Vashisht A; Jurkovic D; Saridogan E
J Minim Invasive Gynecol; 2017; 24(3):485-493. PubMed ID: 28104498
[TBL] [Abstract][Full Text] [Related]
19. Feasibility, Safety, and Prediction of Complications for Minimally Invasive Myomectomy in Women With Large and Numerous Myomata.
Vargas MV; Moawad GN; Sievers C; Opoku-Anane J; Marfori CQ; Tyan P; Robinson JK
J Minim Invasive Gynecol; 2017 Feb; 24(2):315-322. PubMed ID: 27939896
[TBL] [Abstract][Full Text] [Related]
20. Surgical Treatment of Uterine Fibroids Within a Containment System and Without Power Morcellation.
Kho KA; Brown DN
Clin Obstet Gynecol; 2016 Mar; 59(1):85-92. PubMed ID: 26670832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
